|
|||||
|
|
Targeting SWI/SNF mutant cancers with tyrosine kinase inhibitor therapy |
|
| Authors: | Paul H Huang |
| Affiliation: | Division of Cancer Biology, The Institute of Cancer Research, London, UK |
| Abstract: | |
| Keywords: | SWI/SNF SMARCB1 receptor tyrosine kinase tyrosine kinase inhibitor cancer signal transduction |